Express News | Hybio Pharmaceutical: Its wholly-owned subsidiary's Active Pharmaceutical Ingredient for Teriparatide has been accepted by the South Korea MFDS.

Breakings10minutes ago

A-share volatility丨Eli Lilly and Co's strong rise has stimulated the Weight Loss Drugs concept stocks to collectively strengthen, with Jinkai Shengke hitting the 20% limit up and Huadong Medicine rising by 6%.

On April 18, Gelonghui reported that overnight, Eli Lilly and Co surged over 14%, stimulating strong performance in Weight Loss Drugs stocks in the A-share market. Among them, Jinkaisheng Technology reached the daily limit of 20%, Deyuan Pharmaceutical rose over 9%, Huadong Medicine increased over 6%, Beijing Sl Pharmaceutical and Shengnuo Bio rose by 4%, Wanbang Pharmaceutical, Pu reisi, and Hybio Pharmaceutical increased by over 3%. In terms of news, Eli Lilly announced positive Phase 3 trial results for its daily oral GLP-1 drug Orforglipron, aimed at adult patients with type 2 diabetes. Overnight, Eli Lilly's stock price closed with a surge of over 14%.

Gelonghui Finance09:38

Express News | The concept of Weight Loss Drugs was active early in the trading session, with Jinkai Biotechnology rising over 15%.

Breakings09:32

Express News | The concept of Innovative Drugs has fluctuated and surged, with Haisco Pharmaceutical Group hitting a limit-up and setting a historic high.

BreakingsApr 11 14:11

Express News | Hybio Pharmaceutical responds to the U.S. plan to impose tariffs on pharmaceuticals: The main exports to the U.S. are liraglutide and Active Pharmaceutical Ingredient. We are closely monitoring the relevant developments.

BreakingsApr 9 10:27

Express News | CRO Concept stocks opened lower, with Hybio Pharmaceutical falling over 10%.

BreakingsApr 9 09:34